Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A-Reference-Cited by-同舟云学术

Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A

Published:2004-02 Issue:3 Volume:77 Page:339-344
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Giese Thomas,Zeier Martin,Schemmer Peter,Uhl Waldemar,Schoels Margarita,Dengler Thomas,Buechler Markus,Meuer Stefan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference16 articles.

1. Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996

2. Cyclosporin A Toxicity of the Renal Allograft – a Late Complication and Potentially Reversible

3. Immunosuppressive therapies after heart transplantation: best, better, and beyond

4. Comparison of predose vs 2-h postdose blood metabolites/cyclosporine ratios in kidney and liver transplant patients

5. Immunosuppressive Therapy for Paediatric Transplant Patients

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 8th Sino-German symposium on immunology: fostering mutual trust and collaborative endeavors for advancing immunological science;Cellular & Molecular Immunology;2024-05-31

2. Pharmacodynamic monitoring by residual gene expression of the nuclear factor of activated T cell-regulated genes in lung transplant recipients and its correlation with tacrolimus blood levels;Frontiers in Immunology;2024-05-10

3. Early steroids after pediatric liver transplantation protect against T-cell–mediated rejection: Results from the ChilSFree study;Liver Transplantation;2023-09-05

4. Pharmacodynamic Monitoring of Ciclosporin and Tacrolimus: Insights From Nuclear Factor of Activated T-Cell–Regulated Gene Expression in Healthy Volunteers;Therapeutic Drug Monitoring;2023-02

5. Update: Immunsuppression bei Organtransplantationen;DMW - Deutsche Medizinische Wochenschrift;2022-09